Latest Clinical Evidence: Head-to-Head Comparison (Updated February 2026) Weight Loss Effectiveness: The Numbers Dont Lie Mounjaros Superior Results: 21-22% average weight loss in obesity trials over 68-72 weeks 25% weight loss achieved by a significant subset of patients 15.3% weight loss at 12 months in real-world studies Mean weight difference of -6.9% compared to semaglutide Ozempics Strong Performance: 15-20% average weight loss with Wegovy (higher-dose semaglutide) 13.7% weight loss at 72 weeks in head-to-head trials 8.3% weight loss at 12 months in real-world comparisons Proven efficacy for sustained weight management Time-Based Weight Loss Comparison According to Nature Reviews Endocrinology (December 12, 2025): Patients receiving tirzepatide achieved 6% greater weight loss than those receiving semaglutide and were more likely to achieve weight loss of 10%, 15%, and even 20%. Explore Wegovy vs Mounjaro comparison Diabetes Control (HbA1c Reduction) SURPASS-2 Trial Results: Both medications excel at blood sugar management, but Mounjaro shows superior glycaemic control: Mounjaro 5mg : 2.01% HbA1c reduction Mounjaro 10mg : 2.24% HbA1c reduction Mounjaro 15mg : 2.30% HbA1c reduction Ozempic 1mg : 1.86% HbA1c reduction Groundbreaking Cardiovascular Protection (Latest 2025-2026 Studies) One of the most significant developments is the confirmation of cardiovascular benefits from both medications

Application of Guijiaosan Shenque acupoint paste can improve the scores of obesity, endocrine and TCM symptoms in treating obese polycystic ovary syndrome
This tier is best suited for researchers with specific clinical goals that require the last increment of pharmacological effect
Ensure you have a secure method to access and track your prescription information
Simply put, you should aim to consider at least 1.2g to 1.3g of protein per kg of body weight per day when engaging in a weight loss programme
This product surpassed my expectation, within 1 week I lost 5 pounds